Norges Bank Anika Therapeutics, Inc. Transaction History

Norges Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$16.98 - $26.1 $962,766 - $1.48 Million	-56,700 Closed	0 $0
Q2 2023 Aug 14, 2023	SELL	$25.16 - $28.86 $1.43 Million - $1.64 Million	-56,700 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$25.91 - $32.1 $935,351 - $1.16 Million	36,100 New	36,100 $1.04 Million
Q3 2022 Nov 13, 2023	BUY	$21.74 - $24.68 $1.23 Million - $1.4 Million	56,700 New	56,700 $1.35 Million
Q2 2022 Aug 14, 2023	BUY	$20.4 - $25.53 $1.16 Million - $1.45 Million	56,700 New	56,700 $1.27 Million
Q1 2022 May 12, 2023	BUY	$24.7 - $36.54 $1.4 Million - $2.07 Million	56,700 New	56,700 $1.42 Million
Q1 2022 May 09, 2022	SELL	$24.7 - $36.54 $1.4 Million - $2.07 Million	-56,700 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$35.83 - $45.03 $2.03 Million - $2.55 Million	56,700 New	56,700 $2.03 Million

123

11.5M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.